Laura Moschcovich, PhD
Laura Moschcovich joined OPKO Biologics in 2007 as the Head of Downstream Development, leading the development of the purification process of MOD-4023 (CTP-growth hormone). In 2012 she became a Project Manager responsible for overseeing three different projects in collaboration with different CMOs, taking the responsibility of the technology transfer of the processes developed at OPKO Biologics from development to production. In 2015 she led the CMC activities as Vice President, CMC Operations. Since 2019, Laura has served as General Manager.
Prior to joining the company, Laura worked at Target-In Ltd., an Israeli startup in partnership with the Hebrew University of Jerusalem, as Head of Downstream Development, where she was responsible for the development of the purification process of an innovative product. Laura completed a post-doctoral fellowship and received her PhD in Biochemistry from Tel Aviv University.